DBV Technologies DBVT
NASDAQ DBVT
$13.47 -0.23 (-1.68%)
As of: Sep 4, 2026 · 3:59 PM EDT

DBV Technologies (DBVT) Cash & Current Investments (2015 - 2026)

DBV Technologies (DBVT) posted Cash & Current Investments of $174.9 million for Q2 2026, down 23.69% sequentially from $229.2 million in Q1 2026, and up 69.47% YoY from $103.2 million in Q2 2025.

Analysis

DBV Technologies (DBVT) Cash & Current Investments (2015 - 2026) Analysis & Trends

DBV Technologies has reported Cash & Current Investments for 12 years, with the latest figure at $174.9 million in Q2 2026.

  • Quarterly Cash & Current Investments rose 69.47% year-over-year to $174.9 million in Q2 2026, while the trailing twelve-month figure through Jun 2026 was $174.9 million (up 69.47% YoY) and the FY2025 annual result came in at $194.2 million, up 498.35% from the prior year.
  • Cash & Current Investments slipped to $174.9 million in Q2 2026 per DBVT's latest filing, from $229.2 million in the prior quarter.
  • Over five years, Cash & Current Investments peaked at $248.0 million in Q2 2022 and troughed at $13.0 million in Q1 2025.
  • A 5-year average of $135.1 million and a median of $145.3 million in 2023 frame the typical range for Cash & Current Investments.
  • The sharpest annual moves came in 2025 and 2026: Cash & Current Investments sank 87.23% in 2025, then soared 1668.25% in 2026.
  • Over 5 years, Cash & Current Investments stood at $209.2 million in 2022, then plunged by 32.42% to $141.4 million in 2023, then sank by 77.04% to $32.5 million in 2024, then surged by 498.35% to $194.2 million in 2025, then dropped by 9.94% to $174.9 million in 2026.
  • According to Business Quant data, Cash & Current Investments over the past three periods registered $174.9 million, $229.2 million, and $194.2 million for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash & Current Investments (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn 7.85 Bn
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn 7.99 Bn
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn 5.18 Bn
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn 5.14 Bn
5 Revolution Medicines 44.33 Bn 44.33 Bn - -
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn 5.10 Bn
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn 3.31 Bn
8 Royalty Pharma 28.45 Bn 27.61 Bn - 836.99 Mn
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn 1.16 Bn
10 DBV Technologies 5.88 Bn 5.70 Bn - 174.90 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 174.90 Mn
Mar 31, 2026 229.20 Mn
Dec 31, 2025 194.20 Mn
Sep 30, 2025 69.84 Mn
Jun 30, 2025 103.21 Mn
Mar 31, 2025 12.96 Mn
Dec 31, 2024 32.46 Mn
Sep 30, 2024 46.44 Mn
Jun 30, 2024 66.21 Mn
Mar 31, 2024 101.53 Mn
Dec 31, 2023 141.37 Mn
Sep 30, 2023 149.14 Mn
Jun 30, 2023 173.96 Mn
Mar 31, 2023 192.29 Mn
Dec 31, 2022 209.19 Mn
Sep 30, 2022 212.67 Mn
Jun 30, 2022 247.97 Mn
Mar 31, 2022 74.11 Mn
Dec 31, 2021 77.30 Mn
Sep 30, 2021 98.20 Mn